Key facts
- It has raised $250K; the latest was Accelerator/Incubator ($50K) in Feb 2026.
- Notable investors include MassChallenge, Berkeley SkyDeck, First Spark Ventures, Granatus Ventures, Blue Cross Blue Shield of Massachusetts — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Endometrics
- ·The full record, as it builds
Funding rounds
No funding rounds for Endometrics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Endometrics
Operator of a women's health company intended to develop a non-invasive diagnostic test for endometriosis. The company's technology facilitates medical tests that include at-home menstrual blood collection and subsequent laboratory analysis, enabling women to overcome chronic pain associated with endometriosis.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 5
- Website
- endometrics.us/
- Ownership
- Privately Held (backing)
Endometrics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Endometrics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Endometrics in its N-PORT filings yet. We sweep new filings monthly.